Dr. Xiao is a surgical pathologist with a subspecialty focus in gastrointestinal pathology. His diagnostic expertise includes neoplastic and non-neoplastic diseases of the gastrointestinal tract, liver, and biliary tract, and pancreas.
University of Chicago
Chicago
Fellowship - GI and Liver Pathology
1999
University of Chicago
Chicago
Residency - Anatomic and Clinical Pathology
1998
National Institutes of Health
Bethesda, MD
Postdoctoral fellowship - Neurological Disorders
1990
Hubei Medical University
Wuhan
MM - Microbiology and Immunology
1987
Hubei Medical University
Wuhan
BM - Medicine
1984
An empirical analysis of the factors driving customers' purchase intention of green smart home products.
An empirical analysis of the factors driving customers' purchase intention of green smart home products. Front Psychol. 2023; 14:1272889.
PMID: 37965665
Clinicopathologic Features of Chronic Intestinal Schistosomiasis and Its Distinction From Crohn Disease.
Clinicopathologic Features of Chronic Intestinal Schistosomiasis and Its Distinction From Crohn Disease. Am J Surg Pathol. 2021 03 01; 45(3):430-438.
PMID: 32991343
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease.
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
PMID: 33234578
Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis.
Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis. EBioMedicine. 2020 10; 60:103004.
PMID: 32979833
Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility.
Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility. Virchows Arch. 2021 Mar; 478(3):427-434.
PMID: 32895766
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China. J Med Virol. 2020 11; 92(11):2751-2757.
PMID: 32530494
Histologic changes caused by injection of a novel submucosal lifting agent for endoscopic resection in GI lesions.
Histologic changes caused by injection of a novel submucosal lifting agent for endoscopic resection in GI lesions. Gastrointest Endosc. 2021 02; 93(2):470-476.
PMID: 32593688
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic. J Thorac Oncol. 2020 07; 15(7):1119-1136.
PMID: 32422364
Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications.
Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications. J Med Virol. 2020 Sep; 92(9):1491-1494.
PMID: 32369204
Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process.
Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process. J Thorac Oncol. 2020 05; 15(5):e67-e68.
PMID: 32340678